Lower FADD expression was significantly associated with better disease-free survival and overall survival in HNC patients with lymph node metastasis, although FADD expression did not significantly affect the survival of HNC patients without lymph node metastasis [48]. The gene discussed is FADD; the disease is metastatic malignant neoplasm in the lymph nodes.